Phase 2 clinical trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) demonstrated substantial weight reduction in participants with obesity
Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: Systematic Review and Meta-analysis of RCTs
Indeed, the investigation of cross talk between mentioned molecules and tumor stroma may shed light on finding new targets and could provide beneficial information for the rational design of a novel therapeutic approach in cancer
Alternative Therapies in Health and Medicine, 27(4), 813
Enhanced chilling tolerance at the booting stage in rice by transgenic overexpression of the ascorbate peroxidase gene, OsAPXa
the invention describes the lipid encapsulation of the glutathione (reduced) or methylcobalamine into the lipid vesicle of liposomes and administered orally for the transmucosal absorption into the nose, mouth, throat or gastrointestinal tract providing the ability to conveniently supply therapeutically effective amounts of glutathione (reduced) or methylcobalamine